• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醋酸亮丙瑞林长效注射剂用于治疗性早熟。

Depot leuprolide acetate for treatment of precocious puberty.

作者信息

Parker K L, Lee P A

机构信息

Department of Pediatrics, University of Pittsburgh School of Medicine, Pennsylvania.

出版信息

J Clin Endocrinol Metab. 1989 Sep;69(3):689-91. doi: 10.1210/jcem-69-3-689.

DOI:10.1210/jcem-69-3-689
PMID:2503536
Abstract

Leuprolide acetate (D-Leu 6 des-Gly-NH2(10), Pro-ethylamide9) for depot suspension has been shown to be effective in suppressing gonadotropins in 6 patients. Serum LH and FSH response to exogenous LHRH was obliterated after 4 weeks and weekly urinary gonadotropin levels during depot therapy were suppressed. This form of this drug should be effective in the treatment of precocious puberty.

摘要

已证明,用于长效混悬液的醋酸亮丙瑞林(D-亮氨酸6 去甘氨酰胺(10),脯氨酸乙酯9)对6例患者的促性腺激素有抑制作用。4周后,血清促黄体生成素(LH)和促卵泡生成素(FSH)对外源性促性腺激素释放激素(LHRH)的反应消失,长效治疗期间每周的尿促性腺激素水平受到抑制。这种药物剂型应可有效治疗性早熟。

相似文献

1
Depot leuprolide acetate for treatment of precocious puberty.醋酸亮丙瑞林长效注射剂用于治疗性早熟。
J Clin Endocrinol Metab. 1989 Sep;69(3):689-91. doi: 10.1210/jcem-69-3-689.
2
Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty.长效促性腺激素释放激素类似物(醋酸亮丙瑞林,抑那通)对性早熟儿童促性腺激素分泌的抑制作用。
J Clin Endocrinol Metab. 1989 Nov;69(5):1087-9. doi: 10.1210/jcem-69-5-1087.
3
Effects of leuprolide in the treatment of central precocious puberty.亮丙瑞林治疗中枢性性早熟的疗效
J Pediatr. 1989 Feb;114(2):321-4. doi: 10.1016/s0022-3476(89)80806-6.
4
Depot leuprolide acetate dosage for sexual precocity.醋酸亮丙瑞林长效注射剂治疗性早熟的剂量
J Clin Endocrinol Metab. 1991 Jul;73(1):50-2. doi: 10.1210/jcem-73-1-50.
5
A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group.一项关于超长效促黄体生成激素释放激素类似物(醋酸亮丙瑞林缓释剂,TAP - 144 - SR)治疗中枢性性早熟的剂量探索研究。TAP - 144 - SR治疗中枢性性早熟研究组
Endocrinol Jpn. 1991 Aug;38(4):369-76. doi: 10.1507/endocrj1954.38.369.
6
Two-year results of treatment with depot leuprolide acetate for central precocious puberty.醋酸亮丙瑞林长效注射剂治疗中枢性性早熟的两年结果
J Pediatr. 1992 Oct;121(4):634-40. doi: 10.1016/s0022-3476(05)81162-x.
7
Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.长效促性腺激素释放激素类似物治疗中枢性性早熟儿童的长期疗效
Am J Dis Child. 1993 Jun;147(6):653-7. doi: 10.1001/archpedi.1993.02160300059023.
8
A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.在长效醋酸亮丙瑞林注射2小时后进行单次促黄体生成素测定,有助于监测女童促性腺激素依赖性性早熟的治疗情况。
J Clin Endocrinol Metab. 2004 Sep;89(9):4338-42. doi: 10.1210/jc.2003-031537.
9
Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.通过定期给予长效D-色氨酸6-促黄体生成素释放激素微胶囊制剂对男性和女性性早熟进行长期治疗。
J Clin Endocrinol Metab. 1986 Apr;62(4):670-7. doi: 10.1210/jcem-62-4-670.
10
Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy.长效醋酸亮丙瑞林注射后数分钟内血清促黄体生成素升高:对治疗监测的意义。
Pediatrics. 2002 Feb;109(2):E30. doi: 10.1542/peds.109.2.e30.

引用本文的文献

1
The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysis.醋酸亮丙瑞林11.25毫克3个月剂型对中枢性性早熟儿童的影响:一项系统评价和荟萃分析。
Adv Ther. 2025 Jun 11. doi: 10.1007/s12325-025-03222-7.
2
Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls.促性腺激素释放激素类似物和重组人生长激素治疗特发性中枢性性早熟女童。
Front Endocrinol (Lausanne). 2022 Dec 14;13:1085385. doi: 10.3389/fendo.2022.1085385. eCollection 2022.
3
Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty.
1个月和3个月促性腺激素释放激素激动剂长效注射剂治疗中枢性性早熟女童的短期疗效
Ann Pediatr Endocrinol Metab. 2021 Sep;26(3):171-177. doi: 10.6065/apem.2040134.067. Epub 2021 May 12.
4
Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy.比较单纯使用促性腺激素释放激素激动剂治疗的中枢性性早熟女童与联合生长激素治疗的女童之间的成人身高增长和初潮年龄。
Ann Pediatr Endocrinol Metab. 2019 Jun;24(2):116-123. doi: 10.6065/apem.2019.24.2.116. Epub 2019 Jun 30.
5
Gelatin device for the delivery of growth factors involved in endochondral ossification.用于递送参与软骨内骨化的生长因子的明胶装置。
PLoS One. 2017 Apr 5;12(4):e0175095. doi: 10.1371/journal.pone.0175095. eCollection 2017.
6
Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty.醋酸亮丙瑞林长效注射剂(Luphere depot 3.75 mg)治疗中枢性性早熟女童疗效和安全性的多中心临床试验。
Ann Pediatr Endocrinol Metab. 2013 Dec;18(4):173-8. doi: 10.6065/apem.2013.18.4.173. Epub 2013 Dec 31.
7
Pros and cons of GnRHa treatment for early puberty in girls.GnRHa 治疗女童性早熟的利弊。
Nat Rev Endocrinol. 2014 Jun;10(6):352-63. doi: 10.1038/nrendo.2014.40. Epub 2014 Apr 8.
8
Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study.醋酸亮丙瑞林长效注射剂治疗中枢性性早熟(CPP)的疗效:一项前瞻性纵向研究中的生长结果
Int J Pediatr Endocrinol. 2011;2011(1):7. doi: 10.1186/1687-9856-2011-7. Epub 2011 Jul 12.
9
Central precocious puberty: current treatment options.中枢性性早熟:当前的治疗选择。
Paediatr Drugs. 2004;6(4):211-31. doi: 10.2165/00148581-200406040-00002.
10
Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.亮丙瑞林。其药理学及在前列腺癌、子宫内膜异位症和其他性激素相关疾病中的治疗应用综述。
Drugs. 1994 Dec;48(6):930-67. doi: 10.2165/00003495-199448060-00008.